GlassScriptPhysician profile
John J Kresl
NPI 1366418675
$247,849.24
in general payments reported to CMS, 2019-2025
49 companies · $5,891 in 2025
The $5,891 reported for 2025 was more than what 95% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $51K · 2021: $64K · 2022: $5,651 · 2023: $23K · 2024: $54K · 2025: $5,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $70K · Food and Beverage: $9,343 · Travel and Lodging: $3,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,920.00 |
| Food and Beverage | $9,343.22 |
| Travel and Lodging | $3,833.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $112,108.61 | 2019-2021 | |
| Icotec Medical INC. | $46,735.63 | 2022-2025 | Icotec Blackarmor Spine System, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Siemens Medical Solutions USA, INC. | $35,740.69 | 2021-2025 | Varian Ethos Treatment Planning, Aria Radiation Therapy Management Software, Eclipse Treatment Planning System For External Beam Radiation Therapy |
| Carbofix Spine INC | $26,806.04 | 2023-2024 | |
| Accuray Incorporated | $16,658.38 | 2019-2025 | Cyberknife System, Tomo Therapy System |
| Visionrt, INC. | $2,616.00 | 2024 | |
| Elekta, INC. | $1,637.73 | 2019-2025 | Elekta Unity, Elekta Medical Linear Accelerator |
| Viewray Technologies INC | $1,361.72 | 2019-2021 | |
| Zap Surgical Systems, INC. | $980.29 | 2020-2022 | |
| Novocure INC. | $392.73 | 2019-2025 | Optune, Optune Lua (Novottf-200t) |
| Izi Medical Products, LLC | $329.49 | 2024 | |
| Abbvie INC. | $253.02 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $247.70 | 2023-2024 | Orgovyx |
| Blue Earth Diagnostics | $225.85 | 2021-2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $187.46 | 2022-2025 | Imfinzi, Enhertu |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$34,600.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kresl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.